QIAGEN NV has announced the launch of its new QIAseq xHYB Long Read Panels, enhancing its next-generation sequencing $(NGS)$ portfolio. This expansion aims to provide target enrichment solutions that facilitate long-read sequencing of complex genomic regions. The new panels are optimized for native long-read platforms, such as PacBio, and are designed to improve the detection of genomic variations like HLA typing, repeat expansions, and structural variants. This development underscores QIAGEN's commitment to offering comprehensive NGS solutions, catering to both short- and long-read sequencing needs, and empowering researchers in fields ranging from immune profiling to cancer biology.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。